Patent · US Active

Method for presymptomatic diagnosis of coeliac disease and gluten sensitivity

US11686728B2 · kind B2 · utility

0Cited by

2References

8Claims

0Family size

Assignee

Aeneas GmbH & Co. KG · DE

Inventors

Torsten Matthias · Flonheim, DE
Kai Prager · Bad Kreuznach, DE
Christian Meesters · Uhlerborn, DE
Patricia Jeremias · Witzenhausen, DE
Sascha Pfeiffer · Wuppertal, DE

Key dates

Filing date	Feb 18, 2020
Grant date	Jun 27, 2023
Priority date	—
Expiry date	Feb 18, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of an immunologically reactive microbial transglutaminase or its immunologically reactive parts or analogues, which are present in a complex with gliadin or its immunologically reactive parts or analogues, for the diagnosis and/or therapy control of coeliac disease or sprue as well as gluten sensitivity, and a kit for determining the diagnosis and/or therapy control of coeliac disease or sprue as well as of gluten sensitivity, by means of the previously mentioned complex.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.